Elbekai Reem H, El-Kadi Ayman O S
Faculty of Pharmacy and Pharmaceutical Sciences, 3118 Dentistry/Pharmacy Centre, University of Alberta, Edmonton, Alta., T6G 2N8, Canada.
Toxicology. 2004 Oct 1;202(3):249-69. doi: 10.1016/j.tox.2004.05.009.
Aryl hydrocarbon receptor (AhR) ligands and heavy metals are environmental co-contaminants and their molecular interaction may disrupt the coordinated regulation of AhR-dependent phase I and II drug metabolizing enzymes. To determine the effect of heavy metals on the AhR-regulated genes: cytochrome P4501A1 (Cyp1a1), NAD(P)H: quinone oxidoreductase (QOR) and glutathione S-transferase Ya (GST Ya), murine hepatoma Hepa 1c1c7 cells were treated with increasing concentrations of As3+ (1-10 microM), Cd2+ (1-25 microM) and Cr6+ (1-25 microM) with or without the AhR ligands: 2,3,7,8-tetrachlorodibenzo-p-dioxin (0.1 nM), 3-methylcholanthrene (0.25 microM), beta-naphthoflavone (10 uM), or benzo[a]pyrene (1 microM). Our results show that AhR ligands alone and As3+ or Cd2+ alone increased the catalytic activities and mRNA levels of all AhR-regulated genes. When metals were co-administered with an AhR ligand, all three metals inhibited the induction of Cyp1a1 activity by the AhR ligands but potentiated its mRNA and protein expression. In addition, all metals enhanced QOR and GST Ya at the activity and mRNA levels but modulated their induction by AhR ligands in a concentration, metal, and AhR ligand-dependent manner. Generally, Cr6+ inhibited while As3+ and Cd2+ potentiated the induction of QOR and GST Ya activities and mRNA levels. The three metals enhanced the expression of heme oxygenase-1, which coincided with the changes in the phase I and phase II enzyme activities. These results show that the ability of metals to alter the capacity of AhR ligands to induce the bioactivating phase I and the detoxifying phase II enzymes will influence the carcinogenicity and mutagenicity of the AhR ligands.
芳基烃受体(AhR)配体和重金属是环境共污染物,它们之间的分子相互作用可能会破坏AhR依赖性I相和II相药物代谢酶的协调调控。为了确定重金属对AhR调控基因:细胞色素P4501A1(Cyp1a1)、NAD(P)H:醌氧化还原酶(QOR)和谷胱甘肽S-转移酶Ya(GST Ya)的影响,用浓度递增的As3 +(1 - 10微摩尔)、Cd2 +(1 - 25微摩尔)和Cr6 +(1 - 25微摩尔)处理小鼠肝癌Hepa 1c1c7细胞,处理时添加或不添加AhR配体:2,3,7,8 - 四氯二苯并 - p - 二恶英(0.1纳摩尔)、3 - 甲基胆蒽(0.25微摩尔)、β - 萘黄酮(10微摩尔)或苯并[a]芘(1微摩尔)。我们的结果表明,单独的AhR配体以及单独的As3 +或Cd2 +均可增加所有AhR调控基因的催化活性和mRNA水平。当金属与AhR配体共同给药时,所有三种金属均抑制AhR配体对Cyp1a1活性的诱导,但增强其mRNA和蛋白质表达。此外,所有金属均在活性和mRNA水平上增强QOR和GST Ya,但以浓度、金属和AhR配体依赖性方式调节它们被AhR配体的诱导作用。一般来说,Cr6 +抑制而As3 +和Cd2 +增强QOR和GST Ya活性及mRNA水平的诱导。这三种金属增强了血红素加氧酶 - 1的表达,这与I相和II相酶活性的变化一致。这些结果表明,金属改变AhR配体诱导生物活化I相和解毒II相酶能力的作用将影响AhR配体的致癌性和致突变性。